SCHEMBL4285067

SCHEMBL4285067

COC(=O)c1nn(C(c2ccccc2)(c2ccccc2)c2ccccc2)cc1NC(=O)c1cnccn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.47
ALOX15 P16050 3/20 0.47
ALDH1A1 P00352 3/20 0.47
MAPT P10636 1/20 0.47
MCL1 Q07820 1/20 0.47
RAB9A P51151 1/20 0.47
HDAC3 O15379 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
KDM4E B2RXH2 1/20 0.45
LMNA P02545 1/20 0.45
TP53 P04637 1/20 0.45
HTT P42858 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
CYP1A2 P05177 1/20 0.42
POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4286953 0.81 PDE10A (0.42) TSHRALOX15ALDH1A1MAPTMCL1
SCHEMBL4288801 0.80 HTT (0.39) TSHRALOX15ALDH1A1RAB9ASMN1; SMN2
SCHEMBL28916239 0.74 MAPT (0.43) TSHRALOX15ALDH1A1MAPTRAB9A
SCHEMBL3846829 0.71 GAA (0.44) TSHRALOX15ALDH1A1MAPTRAB9A
SCHEMBL4285291 0.71 TP53 (0.44) TSHRALOX15ALDH1A1MAPTRAB9A
SCHEMBL4285857 0.71 TSHR (0.39) TSHRALDH1A1RAB9AKDM4ECYP1A2
SCHEMBL28916204 0.70 KDM4E (0.42) TSHRALOX15ALDH1A1MAPTRAB9A
SCHEMBL4284526 0.69 KDM4E (0.42) TSHRALOX15ALDH1A1MAPTRAB9A
SCHEMBL18064949 0.68 MCL1 (0.73) TSHRALOX15ALDH1A1MAPTMCL1
SCHEMBL4289698 0.68 ALDH1A1 (0.43) ALDH1A1MAPTHTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090156582-A1 Pyrazole Compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-06-18 US disclosed
EP-1847531-A1 PYRAZOLE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2007-10-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156582-A1 Pyrazole Compound GSK3B, GSK3A, GSKIP TSHR 2251/4885ALOX15 4067/4885ALDH1A1 694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.